Showing results (91-100 of 137) with videos related to
Sort By:
Pageof 14
Angewandte Chemie (International Ed. in English)|February 18, 2015
Total syntheses and biological evaluation of miuraenamidesLisa Karmann, Katharina Schultz, Jennifer Herrmann, et al.The Journal of Biological Chemistry|January 19, 2010
Characterization of a novel type of oxidative decarboxylase involved in the biosynthesis of the styryl moiety of chondrochloren from an acylated tyrosineShwan Rachid, Ole Revermann, Christina Dauth, et al.Organic & Biomolecular Chemistry|November 23, 2022
Total synthesis of Myxoprincomide, a secondary metabolite from Myxococcus xanthusMichael Kohr, Christine Walt, Jan Dastbaz, et al.Beilstein Journal of Organic Chemistry|December 5, 2012
Synthetic studies towards bottromycinStefanie Ackermann, Hans-Georg Lerchen, Dieter Häbich, et al.Oncotarget|November 5, 2017
The pretubulysin-induced exposure of collagen is caused by endothelial cell retraction that results in an increased adhesion and decreased transmigration of tumor cellsRebecca Schwenk, Tanja Stehning, Iris Bischoff, et al.Angewandte Chemie (International Ed. in English)|August 9, 2018
Structure, Total Synthesis, and Biosynthesis of Chloromyxamides: Myxobacterial Tetrapeptides Featuring an Uncommon 6-Chloromethyl-5-methoxypipecolic Acid Building BlockJan Gorges, Fabian Panter, Louise Kjaerulff, et al.Organic & Biomolecular Chemistry|December 17, 2004
A straightforward approach towards cyclic peptides via ring-closing metathesis--scope and limitationsUli Kazmaier, Christina Hebach, Anja Watzke, et al.Chemistry & Biology|March 27, 2010
Discovery of 23 natural tubulysins from Angiococcus disciformis An d48 and Cystobacter SBCb004Yi Chai, Dominik Pistorius, Angelika Ullrich, et al.Bioorganic & Medicinal Chemistry|November 5, 2002
Straightforward syntheses of furanomycin derivatives and their biological evaluationUli Kazmaier, Saskia Pähler, Rainer Endermann, et al.Journal of Medicinal Chemistry|July 14, 2012
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndromeLina Yin, Simon Lucas, Frauke Maurer, et al.Pageof 14